Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion

Retina

Volumn 30, Issue 8, 2010, Pages 1254-1261

  Senturk, Fevzi ^a   Ozdemir, Hakan ^a   Karacorlu, Murat ^a   Karacorlu, Serra Arf ^a   Uysal, Omer ^b  

^a Istanbul Retina Institute Inc   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

central retinal vein occlusion; fixation; intravitreal triamcinolone acetonide; macular edema; microperimetry; visual acuity

Indexed keywords

POVIDONE IODINE; PROXYMETACAINE; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; EYE EXAMINATION; EYE FIXATION; FEMALE; HUMAN; INJECTION; MALE; MICROPERIMETRY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PERIMETRY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETINA MACULA EDEMA; THICKNESS; VISUAL ACUITY;

AGED; FEMALE; FIXATION, OCULAR; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINA; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS; VITREOUS BODY;

EID: 77957582701     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181dcfbe7     Document Type: Article

References (15)

1. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997;115:486-491.
2. The Central Vein Occlusion Study Group. Evaluation of grid laser pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 1995;102:1425-1433.
3. Jonas JB, Hayler JK, Sofker A, Panda-Jonas S. Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. J Glaucoma 2001;10:284-287.
4. Danis RP, Ciulla TA, Pratt LM, Ankliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244-250.
5. Karacorlu M, Ozdemir H, Karacorlu S, Alacali N, Mudun B, Burumcek E. Intravitreal triamcinolone acetonide as a primary therapy in diabetic macular oedema. Eye 2005;19:382-386.
6. Karacorlu M, Ozdemir H, Karacorlu S. Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoids macular edema. Acta Ophthalmol Scand 2003;81: 648-652.
7. Ozdemir H, Karacorlu M, Karacorlu S. Regression of serous macular detachment after intravitreal triamcinolone acetonide in cases with diabetic macular edema. Am J Ophthalmol 2005; 140:251-255.
8. Karacorlu M, Karacorlu SA, Ozdemir H, Senturk F. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion. Retina 2007;27: 1026-1030.
9. Karacorlu M, Ozdemir H, Karacorlu S. Intravitreal triamcinolone acetonide for the treatment of central retinal vein occlusion in young cases. Retina 2004;24:324-327.
10. Park CH, Jaffe G, Ferkat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003;136:419-425.
11. Jonas JB, Hayler JK, Söfker A, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy Am J Ophthalmol 2001;131: 468-471.
12. Gregori NZ, Rosenfeld PJ, Puliafito CA, et al. One year safety and efficacy of intravitreal triamcinolone for the management of macular edema secondary to central retinal vein occlusion. Retina 2006;26:889-895.
13. Lamoureux EL, Hassell JB, Keeffe JE. The impact of diabetic retinopathy on participation in daily living. Arch Ophthalmol 2004;122:84-88.
14. Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999;129:324-330.
15. Midena E, Rabin PP, Pilotto E, Ghirlando A, Convento E, Varano M. Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study. Semin Ophthalmol 2004;19:55-61.